The cannabis plant is probably the most active plant on earth, providing countless wellness benefits to afflicted patients. Scientists are slowly but surely maximizing the full potential of the cannabis plant, including what shipping techniques work best for particular circumstances.
One type of cannabis use involves drinking it via cannabis-infused tea preparation. Some patients prefer cannabis-infused teas when accessible because it is a smoke-less cannabis shipping method.
A clinical trial involving fibromyalgia sufferers was just conducted by researchers in Italy. Patients reported pain relief following the consumption of cannabis-infused teas. More details about the test and its results can be found below in a media release from NORML:
Potenza, Italy: The daily consumption of cannabis-infused tea is associated with decreased pain and improved quality of life in fibromyalgia ( FM) patients, according to clinical trial data published in the Journal of Clinical Medicine.
In a cohort of 30 patients with refractory FM, Italian researchers evaluated the potency of cannabis flower ( 22 % THC | 1 % CBD ) steeped in tea. The filled tea was consumed six months of daily.
During the trial, people ‘ median pain scores decreased from 8 ( on a scale of 1 to 10 ) to 4. Additionally, research participants reported improvements in physical and mental health. None of the participants in the trial’s participants reported any negative effects of cannabis.
The study’s authors came to the conclusion that cannabis may be a useful substitute for conventional physiological treatment for treating FM patients. Further studies like random, placebo-controlled clinical tests are needed to confirm these findings”.
Using hemp to effectively manage the signs of the disorder, fibromyalgia patients often self-report. According to observational files released last year, FM people who use medical cannabis products lessen the need for prescription painkillers.
Full wording of the study,” Is a small dose of hemp effective for treating problems related to symptoms? A pilot review and comprehensive review”, appears in the Journal of Clinical Medicine. Software for Cannabis and dditional i for ati Cannabinoids.
This essay first appeared on Internationalcbc.com and is syndicated these with special authority.
Photo by Kimzy Nanney on Unsplash
